- Home
- Publications
- Publication Search
- Publication Details
Title
The aryl hydrocarbon receptor (AhR) as a breast cancer drug target
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-11-13
DOI
10.1002/med.21645
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemical activation of estrogen and aryl hydrocarbon receptor signalling pathways and their interaction in toxicology and metabolism
- (2019) Patrick Tarnow et al. Expert Opinion on Drug Metabolism & Toxicology
- AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer
- (2019) Shawn P. Kubli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety of Oral Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Osteoarthritis: What Does the Literature Say?
- (2019) Cyrus Cooper et al. DRUGS & AGING
- Resveratrol and other dietary polyphenols are inhibitors of estrogen metabolism in human breast cancer cells
- (2019) Stefan Poschner et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Dichlorophenylacrylonitriles as AhR Ligands That Display Selective Breast Cancer Cytotoxicity in vitro
- (2018) Jennifer R. Baker et al. ChemMedChem
- New metalo-therapeutics of NSAIDs against human breast cancer cells
- (2018) Christina N. Banti et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Regulation of the Immune Response by the Aryl Hydrocarbon Receptor
- (2018) Cristina Gutiérrez-Vázquez et al. IMMUNITY
- The aryl hydrocarbon receptor in the crossroad of signalling networks with therapeutic value
- (2018) Ángel C. Roman et al. PHARMACOLOGY & THERAPEUTICS
- High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism
- (2018) Sophie Vacher et al. PLoS One
- The Aryl Hydrocarbon Receptor and Tumor Immunity
- (2018) Ping Xue et al. Frontiers in Immunology
- AhR ligand aminoflavone suppresses α6-integrin-Src-Akt signaling to attenuate tamoxifen resistance in breast cancer cells
- (2018) Petreena S. Campbell et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Putative tumor suppressor cytoglobin promotes aryl hydrocarbon receptor ligand-mediated triple negative breast cancer cell death
- (2018) Leah K. Rowland et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The Aryl Hydrocarbon Receptor: Connecting Immunity to the Microenvironment
- (2018) Rahul Shinde et al. TRENDS IN IMMUNOLOGY
- Acrylamide Functional Group Incorporation Improves Drug-like Properties: An Example with EGFR Inhibitors
- (2018) Kuen-Da Wu et al. ACS Medicinal Chemistry Letters
- Inflammatory breast cancer: Activation of the aryl hydrocarbon receptor and its target CYP1B1 correlates closely with Wnt5a/b-β-catenin signalling, the stem cell phenotype and disease progression
- (2018) Hossam T. Mohamed et al. Journal of Advanced Research
- The crystal structure of the AhRR–ARNT heterodimer reveals the structural basis of the repression of AhR-mediated transcription
- (2017) Shunya Sakurai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- In Vitro Antitumor Effects of AHR Ligands Aminoflavone (AFP 464) and Benzothiazole (5F 203) in Human Renal Carcinoma Cells
- (2017) Gabriela A. Luzzani et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Progesterone receptor in the prostate: A potential suppressor for benign prostatic hyperplasia and prostate cancer
- (2017) RuiQi Chen et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- (Z)-2-(3,4-Dichlorophenyl)-3-(1H-Pyrrol-2-yl)Acrylonitrile Exhibits Selective Antitumor Activity in Breast Cancer Cell Lines via the Aryl Hydrocarbon Receptor Pathway
- (2017) Jayne Gilbert et al. MOLECULAR PHARMACOLOGY
- The Drug Repurposing Hub: a next-generation drug library and information resource
- (2017) Steven M Corsello et al. NATURE MEDICINE
- ClinVar: improving access to variant interpretations and supporting evidence
- (2017) Melissa J Landrum et al. NUCLEIC ACIDS RESEARCH
- Structural hierarchy controlling dimerization and target DNA recognition in the AHR transcriptional complex
- (2017) Seung-Hyeon Seok et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Basis for Aryl Hydrocarbon Receptor-Mediated Gene Activation
- (2017) Kathrin Wiebke Schulte et al. STRUCTURE
- Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval
- (2017) Vinay Prasad et al. JAMA Internal Medicine
- A phase I study of once-weekly aminoflavone prodrug (AFP464) in solid tumor patients.
- (2017) M. P. Goetz et al. JOURNAL OF CLINICAL ONCOLOGY
- The antiandrogen flutamide is a novel aryl hydrocarbon receptor ligand that disrupts bile acid homeostasis in mice through induction of Abcc4
- (2016) Xiaoxia Gao et al. BIOCHEMICAL PHARMACOLOGY
- The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells
- (2016) Elizabeth A. Stanford et al. BMC BIOLOGY
- CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients
- (2016) Maria Simonsson et al. BMC CANCER
- AhR ligand Aminoflavone inhibits α6-integrin expression and breast cancer sphere-initiating capacity
- (2016) Eileen Brantley et al. CANCER LETTERS
- Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer
- (2016) Yuan Tang et al. Clinical Breast Cancer
- Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis
- (2016) An Tran-Duy et al. Clinical Gastroenterology and Hepatology
- Progesterone Receptor Signaling Mechanisms
- (2016) Sandra L. Grimm et al. JOURNAL OF MOLECULAR BIOLOGY
- The possible risks of proton pump inhibitors
- (2016) David J Gracie et al. MEDICAL JOURNAL OF AUSTRALIA
- Resveratrol and its methoxy derivatives modulate the expression of estrogen metabolism enzymes in breast epithelial cells by AhR down-regulation
- (2016) Barbara Licznerska et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Estrogen receptor-α and aryl hydrocarbon receptor involvement in the actions of botanical estrogens in target cells
- (2016) Ping Gong et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Can you teach old drugs new tricks?
- (2016) Nicola Nosengo NATURE
- A comparison of biological characteristics of three strains of Chinese sacbrood virus in Apis cerana
- (2016) Ying Hu et al. Scientific Reports
- Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene
- (2016) Victor Vogel Clinical Interventions in Aging
- Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis
- (2015) Donato F. Romagnolo et al. BMC CANCER
- Aryl Hydrocarbon Receptor Ligand 5F 203 Induces Oxidative Stress That Triggers DNA Damage in Human Breast Cancer Cells
- (2015) Lancelot S. McLean et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Omeprazole Inhibits Pancreatic Cancer Cell Invasion through a Nongenomic Aryl Hydrocarbon Receptor Pathway
- (2015) Un-Ho Jin et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Adjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline
- (2015) O.C. Freedman et al. Current Oncology
- Activation of the Aryl Hydrocarbon Receptor by 10-Cl-BBQ Prevents Insulitis and Effector T Cell Development Independently of Foxp3+Regulatory T Cells in Nonobese Diabetic Mice
- (2015) Allison K. Ehrlich et al. JOURNAL OF IMMUNOLOGY
- Progesterone action in breast, uterine, and ovarian cancers
- (2015) C. H. Diep et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Cytochrome P450 1 family and cancers
- (2015) Ryeo-Eun Go et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Tranilast: A review of its therapeutic applications
- (2015) Sara Darakhshan et al. PHARMACOLOGICAL RESEARCH
- The Aryl Hydrocarbon Receptor: Multitasking in the Immune System
- (2014) Brigitta Stockinger et al. Annual Review of Immunology
- Mono-substituted isopropylated triaryl phosphate, a major component of Firemaster 550, is an AHR agonist that exhibits AHR-independent cardiotoxicity in zebrafish
- (2014) Cory V. Gerlach et al. AQUATIC TOXICOLOGY
- BRCA1 And Estrogen/Estrogen Receptor In Breast Cancer: Where They Interact?
- (2014) Li Wang et al. International Journal of Biological Sciences
- Molecular dynamics simulation studies for DNA sequence recognition by reactive metabolites of anticancer compounds
- (2014) Khaled M. Tumbi et al. JOURNAL OF MOLECULAR RECOGNITION
- A Novel Compound, NK150460, Exhibits Selective Antitumor Activity against Breast Cancer Cell Lines through Activation of Aryl Hydrocarbon Receptor
- (2014) K. Fukasawa et al. MOLECULAR CANCER THERAPEUTICS
- Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes
- (2014) A R Daniel et al. ONCOGENE
- Benzimidazoisoquinolines: A New Class of Rapidly Metabolized Aryl Hydrocarbon Receptor (AhR) Ligands that Induce AhR-Dependent Tregs and Prevent Murine Graft-Versus-Host Disease
- (2014) Sumit Punj et al. PLoS One
- Differential Effects of Omeprazole and Lansoprazole Enantiomers on Aryl Hydrocarbon Receptor in Human Hepatocytes and Cell Lines
- (2014) Aneta Novotna et al. PLoS One
- The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells
- (2014) E F O'Donnell et al. Cell Death & Disease
- The influence of ionic liquids on the Knoevenagel condensation of 1H-pyrrole-2-carbaldehyde with phenyl acetonitriles – cytotoxic 3-substituted-(1H-pyrrol-2-yl)acrylonitriles
- (2014) Ahmed Al Otaibi et al. RSC Advances
- Comparative Analysis of Homology Models of the Ah Receptor Ligand Binding Domain: Verification of Structure–Function Predictions by Site-Directed Mutagenesis of a Nonfunctional Receptor
- (2013) Domenico Fraccalvieri et al. BIOCHEMISTRY
- Beta-naphthoflavone (DB06732) mediates estrogen receptor-positive breast cancer cell cycle arrest through AhR-dependent regulation of PI3K/AKT and MAPK/ERK signaling
- (2013) Chun Wang et al. CARCINOGENESIS
- A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases
- (2013) Gaetano Aurilio et al. EUROPEAN JOURNAL OF CANCER
- Activation of Aryl Hydrocarbon Receptor (AhR) by Tranilast, an Anti-allergy Drug, Promotes miR-302 Expression and Cell Reprogramming
- (2013) Wenxiang Hu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure and Dimerization Properties of the Aryl Hydrocarbon Receptor PAS-A Domain
- (2013) D. Wu et al. MOLECULAR AND CELLULAR BIOLOGY
- Reactivation of Estrogen Receptor α by Vorinostat Sensitizes Mesenchymal-Like Triple-Negative Breast Cancer to Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor
- (2013) Karri Stark et al. PLoS One
- Role of the Aryl Hydrocarbon Receptor in Carcinogenesis and Potential as a Drug Target
- (2013) Stephen Safe et al. TOXICOLOGICAL SCIENCES
- New insights in bilirubin metabolism and their clinical implications
- (2013) Eva Sticova WORLD JOURNAL OF GASTROENTEROLOGY
- Focused library development of 2-phenylacrylamides as broad spectrum cytotoxic agents
- (2012) Mark Tarleton et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer
- (2012) N R West et al. BRITISH JOURNAL OF CANCER
- The Aryl Hydrocarbon Receptor Complex and the Control of Gene Expression
- (2012) Timothy V. Beischlag et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Cytotoxic 2-phenyacrylnitriles, the importance of the cyanide moiety and discovery of potent broad spectrum cytotoxic agents
- (2012) Mark Tarleton et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1
- (2012) Serena L. Clark et al. Computational and Structural Biotechnology Journal
- Activation of the aryl hydrocarbon receptor represses mammosphere formation in MCF-7 cells
- (2011) Shuai Zhao et al. CANCER LETTERS
- Mechanism of a Concentration-dependent Switch between Activation and Inhibition of Arp2/3 Complex by Coronin
- (2011) Su-Ling Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- New Aryl Hydrocarbon Receptor Homology Model Targeted To Improve Docking Reliability
- (2011) Ilaria Motto et al. Journal of Chemical Information and Modeling
- The resurgence of covalent drugs
- (2011) Juswinder Singh et al. NATURE REVIEWS DRUG DISCOVERY
- Regulatory T Cells Get Their Chance to Shine
- (2011) M. Leslie SCIENCE
- A flow chemistry route to 2-phenyl-3-(1H-pyrrol-2-yl)propan-1-amines
- (2011) Mark Tarleton et al. TETRAHEDRON LETTERS
- Contributions of the Ah receptor to bilirubin homeostasis and its antioxidative and atheroprotective functions
- (2010) Karl Walter Bock et al. BIOLOGICAL CHEMISTRY
- Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1 Expression in an AhR-Independent Fashion
- (2010) E. Terzuoli et al. CANCER RESEARCH
- Promoter hypermethylation of BRCA1 correlates with absence of expression in hereditary breast cancer tumors
- (2010) Teresa Tapia et al. Epigenetics
- Issues and updates: evaluating estrogen receptor-α, progesterone receptor and HER2 in breast cancer
- (2010) D Craig Allred MODERN PATHOLOGY
- Association of Human Cytochrome P450 1A1 (CYP1A1) and Sulfotransferase 1A1 (SULT1A1) Polymorphisms with Differential Metabolism and Cytotoxicity of Aminoflavone
- (2010) Q. Zheng et al. MOLECULAR CANCER THERAPEUTICS
- Breast Cancer Stem-Like Cells Are Inhibited by a Non-Toxic Aryl Hydrocarbon Receptor Agonist
- (2010) Gérald J. Prud'homme et al. PLoS One
- The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor
- (2010) Edmond F. O'Donnell et al. PLoS One
- Library synthesis and cytotoxicity of a family of 2-phenylacrylonitriles and discovery of an estrogen dependent breast cancer lead compound
- (2010) Mark Tarleton et al. MedChemComm
- Detection of the TCDD Binding-Fingerprint within the Ah Receptor Ligand Binding Domain by Structurally Driven Mutagenesis and Functional Analysis
- (2009) Alessandro Pandini et al. BIOCHEMISTRY
- Relevance of the aryl hydrocarbon receptor (AhR) for clinical toxicology
- (2009) Tracey D. Bradshaw et al. CLINICAL TOXICOLOGY
- The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy
- (2009) Shu Zhang et al. ENDOCRINE-RELATED CANCER
- Modeling of the Aryl Hydrocarbon Receptor (AhR) Ligand Binding Domain and Its Utility in Virtual Ligand Screening to Predict New AhR Ligands
- (2009) William H. Bisson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Principles of Ligand Binding within a Completely Buried Cavity in HIF2α PAS-B
- (2009) Jason Key et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Aryl Hydrocarbon Receptor Regulates Cell Cycle Progression in Human Breast Cancer Cells via a Functional Interaction with Cyclin-Dependent Kinase 4
- (2009) M. A. Barhoover et al. MOLECULAR PHARMACOLOGY
- Bilirubin and glutathione have complementary antioxidant and cytoprotective roles
- (2009) T. W. Sedlak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Artificial ligand binding within the HIF2 PAS-B domain of the HIF2 transcription factor
- (2009) T. H. Scheuermann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure and Signaling Mechanism of Per-ARNT-Sim Domains
- (2009) Andreas Möglich et al. STRUCTURE
- 2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole is a ligand and shows species-specific partial agonism of the aryl hydrocarbon receptor
- (2009) Rana Bazzi et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The aryl hydrocarbon receptor is a modulator of anti-viral immunity
- (2008) Jennifer L. Head et al. BIOCHEMICAL PHARMACOLOGY
- The aryl hydrocarbon receptor (AhR) pathway as a regulatory pathway for cell adhesion and matrix metabolism
- (2008) Tiffany Kung et al. BIOCHEMICAL PHARMACOLOGY
- Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways
- (2008) Thomas Haarmann-Stemmann et al. BIOCHEMICAL PHARMACOLOGY
- The role of the aryl hydrocarbon receptor in the female reproductive system
- (2008) Isabel Hernández-Ochoa et al. BIOCHEMICAL PHARMACOLOGY
- AHR-mediated immunomodulation: The role of altered gene transcription
- (2008) Nancy I. Kerkvliet BIOCHEMICAL PHARMACOLOGY
- Thalidomide for treatment of multiple myeloma: 10 years later
- (2008) A. Palumbo et al. BLOOD
- BRCA1 transcriptional activity is enhanced by interactions between its AD1 domain and AhR
- (2008) Hyo Jin Kang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Raloxifene
- (2008) Marit D Moen et al. DRUGS
- NSAIDs and breast cancer: a possible prevention and treatment strategy
- (2008) A. Agrawal et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Constitutive regulation ofCYP1B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissue
- (2007) Xinhai Yang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Biological activities of a novel selective oestrogen receptor modulator derived from raloxifene (Y134)
- (2006) M Ning et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started